Get global visibility for your company through The Swedish Drug Development Pipeline.

You can now contribute to this year's pipeline report! SwedenBIO annually inventories the R&D portfolio of Swedish drug projects, which is presented in The Swedish Drug Development Pipeline Report.

By completing the questionnaire, you ensure that accurate information about your company is presented in the report.

Link to the survey: The Swedish Drug Development Pipeline 2016

Purpose of the report?
The report is an important tool for marketing Swedish life science globally and specifically highlighting Swedish companies active in pharmaceutical research and development. Being included in the report gives the individual company global exposure. The report is also produced to provide a national overview of the industry and its needs in order to influence future investments in the life science sector where they are most needed.

Who can participate?
All biotech and pharmaceutical companies with main operations and R&D activities in Sweden that have projects in preclinical and/or clinical trials. Projects that have their regulatory affiliation in medical or veterinary medicine are not requested in this survey.

Win tickets to Nordic Life Science Days September 12-14, 2017!
By filling out the form, you are entered into a draw for two tickets to the largest partnering conference in the Nordic region, Nordic Life Science Days 2017.

Contact Nicole Hanzon, Project Manager,, tel: 0706 – 96 36 33.

Report release on December 7
This year’s report will be launched and presented at the SwedenBIO Summit at the Grand Hotel in Stockholm on December 7. The afternoon brings together industry leaders and specialists for inspiration, discussion and a final bubbly session. Read more and register for the SwedenBIO Summit here.

Download The Swedish Drug Development Pipeline Reports 2006 – 2015 at